Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dyno Therapeutics
Biotech
Astellas, Dyno unearth $15M muscle disorder capsid
Astellas Pharma has reached an agreement to license a Dyno Therapeutics AAV capsid engineered for therapeutic delivery to skeletal muscle.
Will Maddox
Apr 8, 2026 8:00am
Roche bets up to $1B to expand Dyno gene therapy delivery pact
Oct 24, 2024 10:40am
Astellas inks $1.6B pact with Dyno to continue gene therapy play
Dec 1, 2021 7:00pm
Roche's gene therapy plans take Shape with $3B-plus deal
Aug 24, 2021 11:05am
Dyno grabs $100M to expand tech, ink more gene therapy deals
May 6, 2021 7:00am
Dyno, Roche strike $1.8B deal to tackle gene therapy
Oct 14, 2020 6:00am